CRISPR Therapy Fights Rare Disease Where Protein Clogs Organs
TUESDAY, June 29, 2021 (HealthDay News) — Early research suggests that CRISPR gene-editing technology may some day lead to dramatic relief for patients struggling with amyloidosis, a rare but serious disease that can trigger organ failure. “There are many different types of amyloidosis,” explained study author Dr. Julian Gillmore, aContinue Reading